144 related articles for article (PubMed ID: 36790139)
1. Cortactin expression in a Norwegian cohort of human papilloma virus negative oral squamous cell carcinomas of the mobile tongue.
Sengüven Toközlü B; Sapkota D; Vallenari EM; Schreurs O; Søland TM
Eur J Oral Sci; 2023 Apr; 131(2):e12925. PubMed ID: 36790139
[TBL] [Abstract][Full Text] [Related]
2. High-risk human papilloma virus was not detected in a Norwegian cohort of oral squamous cell carcinoma of the mobile tongue.
Søland TM; Bjerkli IH; Georgsen JB; Schreurs O; Jebsen P; Laurvik H; Sapkota D
Clin Exp Dent Res; 2021 Feb; 7(1):70-77. PubMed ID: 33140903
[TBL] [Abstract][Full Text] [Related]
3. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
[TBL] [Abstract][Full Text] [Related]
5. EphA8 is a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma.
Liu L; Wang X; Ge W
Med Sci Monit; 2018 Oct; 24():7213-7222. PubMed ID: 30300334
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors 2, 4, and 9 in primary, metastasized, and recurrent oral tongue squamous cell carcinomas.
Mäkinen LK; Ahmed A; Hagström J; Lehtonen S; Mäkitie AA; Salo T; Haglund C; Atula T
J Oral Pathol Med; 2016 May; 45(5):338-45. PubMed ID: 26426362
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts provide a suitable microenvironment for tumor development and progression in oral tongue squamous cancer.
Li H; Zhang J; Chen SW; Liu LL; Li L; Gao F; Zhuang SM; Wang LP; Li Y; Song M
J Transl Med; 2015 Jun; 13():198. PubMed ID: 26094024
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tertiary lymphoid structures in early clinical stage oral tongue squamous cell carcinoma.
Wang C; Huang Z; Zhang M; Xiong G; Chen X; Xie N
J Oral Pathol Med; 2021 Sep; 50(8):776-784. PubMed ID: 34124806
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
[TBL] [Abstract][Full Text] [Related]
11. Pattern and localization of perineural invasion predict poor survival in oral tongue carcinoma.
Caponio VCA; Troiano G; Togni L; Zhurakivska K; Santarelli A; Laino L; Rubini C; Lo Muzio L; Mascitti M
Oral Dis; 2023 Mar; 29(2):411-422. PubMed ID: 33964054
[TBL] [Abstract][Full Text] [Related]
12. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of UTX promotes tumor progression in Oral tongue squamous cell carcinoma patients receiving surgical resection: a case control study.
Chen YH; Chen CH; Chien CY; Su YY; Luo SD; Li SH
BMC Cancer; 2021 Sep; 21(1):979. PubMed ID: 34465286
[TBL] [Abstract][Full Text] [Related]
14. Validation of the International Tumor Budding Consensus Conference (2016) recommendations in oral tongue squamous cell carcinoma.
Xie N; Yu P; Liu H; Liu X; Hou J; Chen X; Huang H; Wang C
J Oral Pathol Med; 2019 Jul; 48(6):451-458. PubMed ID: 30927486
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic grading and its relationship with outcome in oral tongue squamous cell carcinoma.
Silva LABD; Lopes MLDS; Sá MC; de Almeida Freitas R; Coletta RD; da Silveira EJD; da Costa Miguel MC
J Oral Pathol Med; 2021 Feb; 50(2):183-190. PubMed ID: 33151566
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Kawasaki G; Mizuno A; Nemoto TK
Pathol Oncol Res; 2010 Dec; 16(4):523-31. PubMed ID: 20069395
[TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma.
Kang J; Su M; Xu Q; Wang C; Yuan X; Han Z
Oral Dis; 2023 Mar; 29(2):628-638. PubMed ID: 34455659
[TBL] [Abstract][Full Text] [Related]
18. The prognostic role of combining Krüppel-like factor 4 score and grade of inflammation in a Norwegian cohort of oral tongue squamous cell carcinomas.
Søland TM; Solhaug MB; Bjerkli IH; Schreurs O; Sapkota D
Eur J Oral Sci; 2022 Jun; 130(3):e12866. PubMed ID: 35363406
[TBL] [Abstract][Full Text] [Related]
19. Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
Pandey S; Søland TM; Bjerkli IH; Sand LP; Petersen FC; Costea DE; Senguven B; Sapkota D
Head Neck; 2021 Nov; 43(11):3374-3385. PubMed ID: 34338386
[TBL] [Abstract][Full Text] [Related]
20. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]